Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 6 Month Observational Multicentric Prospective Study Observing the Use of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II Disorder, in the Course of a Major Depressive Episode

NCT00888264 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00888264
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00888264 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 6 Month Observational Multicentric Prospective Study Observing the Use of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II Disorder, in the Course of a Major Depressive Episode
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
May 31, 2009
Completion date
August 31, 2010
Enrollment
152 (estimated)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorders